6Harris AL.Anti-angiogenesis therapy and sirategies for integrating it with adjuvant therapy[J].Recent Result Cancer Res,1998,152:341-352.
7Folkman J.Tumor angiogenesis,a possible control point in tumor growth[J].Ann Intren,1975,82(1):96-100.
8Folkman J,Watson K,Ingber D,et al.Induction of angiogenesis during the transition from byperplnsia to neoplasis[J].Nature,1989,399(6219):58-61.
9O'Reilly MS,Holmgren L,Shing Y,et al.Angiostatin:A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma[J].Cell,1994,79(2):315-328.
10O'Reilly MS,Boehm T,ShingY,et al.Endostatin:An endogenous inhibitor of angiogenesis and tumor growth[J].Cell,1997,88(2):277-285.
2Bramson J, Hitt M, Gallichan WS, et al. Construction of a double recombinant adenovirus vector expressing a heterodimeric cyto- kine: in vitro and in vivo production of biologically active interleukin-12 [J]. Hum Gene Ther, 1996, 7 (3): 333-342.
3Ma X, Trinchieri G. Regulation of interleukin-12 production in antigen-presenting cells [J ]. Adv Immuuol, 2001, 79( 1 ): 55-92.
4Robson NC, Beacock-Sharp H, Donachie AM, et al. The role of antigen -presenting cells and interleukin-12 in the priming of antigen-specific CD4： T cells by immune stimulating complexes [ J ]. Immunology, 2003, 110 ( 1 ): 95-104.
5Schmitt E, Hoehn P, Huels C, eta/. T helper type 1 development of naive CD4- T cells requires the coordinate action of inter- leukin-12 and interferon-gamma and is inhibited by trans- forming growth factor-beta [J]. Eur J Immunol, 1994, 24 (4): 793-798.
6Kang BY, Kim E, Kim TS. Regulatory mechanisms and their therapeutic implications of interleukin-12 production in immune cells [J]. Cell Signal, 2005, 17 (6): 665-673.
7Kiniwa M, Gately M, Gubler U, et d. Recombinant interleukin- 12 suppresses the synthesis of immunoglobulin E by interleukin- 4 stimulated human lymphocytes[J]. J Clin Invest, 1992, 90 (1): 262-266.
8Cooper D, Pride MW, Guo M, et ol. Interleukin-12 redirects murine immune responses to soluble or aluminum phosphate adsorbed HSV-2 glycoprotein D towards Thl and CD4 +CTL responses [J]. Vaccine, 2004, 23 (2): 236-246.
9Gupta S, Boppana R, Mishra GC, et 01. Interleukin-12 is necessary for the priming of CD4+ T cells required during the elicitation of HIV-1 gpl20-specific cytotoxic T-lymphocyte func- tion [J]. Immunology, 2008, 124 (4): 553-561.
10Tsai YS, Shiau AL, Chen YF, et O1. Enhancement of antitumor immune response by targeted interleukin-12 electrogene transfer though antiHER2 single-chain antibody in a murine bladder tumor model [J]. Vaccine, 2009, 27 (39): 5383-5392.
